Document is current
Any future updates will be listed below
-
Authors
Tisakova, Lenka Podpera
Schwebs, Timo
Berdaguer, Rocío
von Freyberg, Marina
Foessleitner, Philipp
Kieninger, Ann-Katrin
Poljak, Albina
Corsini, Lorenzo
Farr, Alex
-
Funding
Funding for this research was provided by:
BioNTech R&D Austria GmbH
Österreichische Forschungsförderungsgesellschaft (FO999896440)
- License Information
-
More Information
Article History
Received: 16 December 2024
Accepted: 21 June 2025
First Online: 12 August 2025
Competing interests
: L.P.T., T.S., R.B., M.F., AK.K., A.P., and L.C. are employees of BioNTech R&D (Austria) GmbH (former PhagoMed Biopharma GmbH) and own BioNTech stocks. L.C. is one of the founders of PhagoMed Biopharma GmbH. A.F. is on the Advisory Board for Pierre Fabre, BioNTech, Avodes and Schuelke, a recipient of honoraria from Exeltis, Dr.Kade, Medinova and Pierre Fabre and holds a copyright from Medinova. P.F. reports no conflict of interest.
: This study was approved by the Ethics Committee of the Medical University in Vienna (EK number: 2385/2020) on 26.01.2021. Written informed consent was obtained from all study participants prior to enrollment.
